Product Code: PHA1247
The global Clinical Trial Imaging market is projected to grow at a CAGR of 7.5% by 2033.
“The Clinical Trial Imaging Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Factors such as Increasing Demand for More Precise and Personalized Treatments and Growing Number of Clinical Trials Are Driving the Market Growth
Clinical trial imaging has the potential to personalize treatments by detecting patients who have specific genetic or disease subtype characteristics that would benefit from a specific drug or treatment. By doing so, the effectiveness of treatments can be enhanced and the possibility of harmful side effects can be reduced. With the increasing demand for novel and enhanced drugs and therapies, the number of clinical trials being conducted worldwide is on the rise. Clinical trial imaging plays a crucial role in these trials by allowing researchers to visualize and quantify the impact of experimental drugs and therapies on the body. Advanced medical imaging techniques like MRI, CT scans, and PET scans offer intricate images of organs, tissues, and cells, enabling identification and monitoring of disease progression, as well as evaluation of the safety and effectiveness of new treatments.
Shortage of Skilled Professional
A major limitation for the clinical trial imaging market is the scarcity of proficient experts. The proficient execution of clinical trial imaging demands skilled professionals such as radiologists, imaging technicians, and data analysts who are trained in the handling of medical imaging technology and possess expertise in data analysis and interpretation. Unfortunately, there is a lack of skilled professionals in the medical imaging field, making it difficult for companies to recruit and retain them. This shortage is more noticeable in emerging markets and specialized areas of imaging, such as nuclear medicine and molecular imaging.
What Questions Should You Ask before Buying a Market Research Report?
- How is the clinical trial imaging market evolving?
- What is driving and restraining the clinical trial imaging market?
- How will each clinical trial imaging submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each clinical trial imaging submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading clinical trial imaging markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- How will the industry evolve during the period between 2020 and 2033? What are the implications of clinical trial imaging projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the clinical trial imaging market?
- Where is the clinical trial imaging market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial imaging market today, and over the next 10 years:
- Our 272-page report provides 115 tables and 162 charts/graphs exclusively to you
- The report highlights key lucrative areas in the industry so you can target them - NOW
- It contains in-depth analysis of global, regional and national sales and growth
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the clinical trial imaging market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
- You will find original analyses, with business outlooks and developments
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial imaging prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report:
Software and Services
Modality
- Computed Tomography
- Magnetic Resonance Imaging
- Ultrasound
- Positron Emission Tomography
- X-ray
- Echocardiography
Therapeutic Area
- Oncology
- Infectious Diseases
- Neurology
- CVS
- Endocrinology
- Immunological Disorder
End-users
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Manufacturer
- Contract Research Organisations
- Academic and Government Research Institutes
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
Europe
- Germany
- Spain
- United Kingdom
- France
- Russia
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC Countries
- South Africa
- Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Imaging Market, 2023 to 2033, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth:
- BioTelemetry, a Philips Company
- Calyx
- Clario
- eClinical Solutions LLC
- ICON plc
- IXICO plc
- Medical Metrics, Inc
- Medpace
|
- Medrio, Inc
- Novitas Life Sciences
- Parexel International Corporation
- Perspectum
- Radiant Sage LLC
- Resonance Health Ltd
- Signant Health
|
Overall world revenue for clinical trial imaging market, 2023 to 2033 in terms of value the market will surpass US$1,370.7 million in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the clinical trial imaging market, 2023 to 2033 report help you?
In summary, our 270+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for clinical trial imaging market, 2023 to 2033 Market, with forecasts for software and services, modality, therapeutics, end users and company size, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for four regional and 20 key national markets - See forecasts for the clinical trial imaging Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the clinical trial imaging Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the clinical trial imaging market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Clinical Trial Imaging Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Reports
- 1.10 About
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
- 3.2.1.2 Increasing demand for more precise and personalized treatments and diagnosis
- 3.2.1.3 Technological advancements in imaging modalities
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Shortage and high costs of skilled professional
- 3.2.2.2 High cost of imaging equipment and services
- 3.2.2.3 Regulatory Challenges
- 3.2.3 Market Opportunities
- 3.2.3.1 Outsourcing of imaging services
- 3.2.3.2 Growing prevalence of chronic diseases
- 3.2.3.3 Increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter's Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
4 Clinical Trial Imaging Market Analysis by Software and Services
- 4.1 Key Findings
- 4.2 Software and Services Segment: Market Attractiveness Index
- 4.3 Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
- 4.4 Services
- 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.4.3 Services, 2023-2033 (US$ Million)
- 4.5 Software
- 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Clinical Trial Imaging Market Analysis by Modality
- 5.1 Key Findings
- 5.2 Modality Segment: Market Attractiveness Index
- 5.3 Clinical Trial Imaging Market Size Estimation and Forecast by Modality
- 5.4 Computed Tomography
- 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.4.2 Market Share by Region, 2023 & 2033 (%)
- 5.5 Magnetic Resonance Imaging
- 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.5.2 Market Share by Region, 2023 & 2033 (%)
- 5.6 Ultrasound
- 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.6.2 Market Share by Region, 2023 & 2033 (%)
- 5.7 Positron Emission Tomography
- 5.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.7.2 Market Share by Region, 2023 & 2033 (%)
- 5.8 X-ray
- 5.8.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.8.2 Market Share by Region, 2023 & 2033 (%)
- 5.9 Echocardiography
- 5.9.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.9.2 Market Share by Region, 2023 & 2033 (%)
6 Clinical Trial Imaging Market Analysis by Therapeutic Area
- 6.1 Key Findings
- 6.2 Therapeutic Area Segment: Market Attractiveness Index
- 6.3 Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
- 6.4 Oncology
- 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.4.2 Market Share by Region, 2023 & 2033 (%)
- 6.5 Infectious diseases
- 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.5.2 Market Share by Region, 2023 & 2033 (%)
- 6.6 Neurology
- 6.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.6.2 Market Share by Region, 2023 & 2033 (%)
- 6.7 CVS
- 6.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.7.2 Market Share by Region, 2023 & 2033 (%)
- 6.8 Endocrinology
- 6.8.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.8.2 Market Share by Region, 2023 & 2033 (%)
- 6.9 Immunological Disorder
- 6.9.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.9.2 Market Share by Region, 2023 & 2033 (%)
7 Clinical Trial Imaging Market Analysis by End Users
- 7.1 Key Findings
- 7.2 End Users Segment: Market Attractiveness Index
- 7.3 Clinical Trial Imaging Market Size Estimation and Forecast by End Users
- 7.4 Pharmaceutical Companies
- 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.4.2 Market Share by Region, 2023 & 2033 (%)
- 7.5 Biotechnology Companies
- 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.5.2 Market Share by Region, 2023 & 2033 (%)
- 7.6 Medical Device Manufacturer
- 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.6.2 Market Share by Region, 2023 & 2033 (%)
- 7.7 Contract Research Organizations
- 7.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.7.2 Market Share by Region, 2023 & 2033 (%)
- 7.8 Academic and Government Research Institutes
- 7.8.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.8.2 Market Share by Region, 2023 & 2033 (%)
8 Clinical Trial Imaging Market Analysis by Region
- 8.1 Key Findings
- 8.2 Regional Market Size Estimation and Forecast
9 North America Clinical Trial Imaging Market Analysis
- 9.1 Key Findings
- 9.2 North America Clinical Trial Imaging Market Attractiveness Index
- 9.3 North America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
- 9.4 North America Clinical Trial Imaging Market Size Estimation and Forecast by Country
- 9.5 North America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
- 9.6 North America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
- 9.7 North America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
- 9.8 North America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
- 9.9 U.S. Clinical Trial Imaging Market Analysis
- 9.10 Canada Clinical Trial Imaging Market Analysis
10 Europe Clinical Trial Imaging Market Analysis
- 10.1 Key Findings
- 10.2 Europe Clinical Trial Imaging Market Attractiveness Index
- 10.3 Europe Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
- 10.4 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Country
- 10.5 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
- 10.6 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Modality
- 10.7 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
- 10.8 Europe Clinical Trial Imaging Market Size Estimation and Forecast by End Users
- 10.9 Germany Clinical Trial Imaging Market Analysis
- 10.10 France Clinical Trial Imaging Market Analysis
- 10.11 U.K. Clinical Trial Imaging Market Analysis
- 10.12 Italy Clinical Trial Imaging Market Analysis
- 10.13 Spain Clinical Trial Imaging Market Analysis
- 10.14 Russia Clinical Trial Imaging Market Analysis
- 10.15 Rest of Europe Clinical Trial Imaging Market Analysis
11 Asia Pacific Clinical Trial Imaging Market Analysis
- 11.1 Key Findings
- 11.2 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
- 11.3 Asia Pacific Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
- 11.4 Asia Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Country
- 11.5 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
- 11.6 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Modality
- 11.7 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
- 11.8 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by End Users
- 11.9 China Clinical Trial Imaging Market Analysis
- 11.10 Japan Clinical Trial Imaging Market Analysis
- 11.11 India Clinical Trial Imaging Market Analysis
- 11.12 Australia Clinical Trial Imaging Market Analysis
- 11.13 South Korea clinical trial imaging Market Analysis
- 11.14 Rest of Asia Pacific Clinical Trial Imaging Market Analysis
12 Latin America Clinical Trial Imaging Market Analysis
- 12.1 Key Findings
- 12.2 Latin America Clinical Trial Imaging Market Attractiveness Index
- 12.3 Latin America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
- 12.4 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Country
- 12.5 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
- 12.6 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
- 12.7 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
- 12.8 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
- 12.9 Brazil Clinical Trial Imaging Market Analysis
- 12.10 Mexico Clinical Trial Imaging Market Analysis
- 12.11 Rest of Latin America Clinical Trial Imaging Market Analysis
13 MEA Clinical Trial Imaging Market Analysis
- 13.1 Key Findings
- 13.2 MEA Clinical Trial Imaging Market Attractiveness Index
- 13.3 MEA Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
- 13.4 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Country
- 13.5 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
- 13.6 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Modality
- 13.7 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
- 13.8 MEA Clinical Trial Imaging Market Size Estimation and Forecast by End Users
- 13.9 GCC Clinical Trial Imaging Market Analysis
- 13.10 South Africa Clinical Trial Imaging Market Analysis
- 13.11 Rest of MEA Clinical Trial Imaging Market Analysis
14 Company Profiles
- 14.1 Competitive Landscape, 2022
- 14.2 Strategic Outlook
- 14.3 ICON plc
- 14.3.1 Company Snapshot
- 14.3.2 Company Overview
- 14.3.3 Financial Analysis
- 14.3.3.1 Revenue, 2018-2022
- 14.3.3.2 Regional Market Shares, 2022
- 14.3.4 Product Benchmarking
- 14.3.5 Strategic Outlook
- 14.4 BioTelemetry, a Philips Company
- 14.4.1 Company Snapshot
- 14.4.2 Company Overview
- 14.4.3 Financial Analysis
- 14.4.3.1 Revenue, 2018-2022
- 14.4.3.2 Regional Market Shares, 2021
- 14.4.3.3 R&D Expense, 2017-2021
- 14.4.4 Product Benchmarking
- 14.4.5 Strategic Outlook
- 14.5 Clario
- 14.5.1 Company Snapshot
- 14.5.2 Company Overview
- 14.5.3 Product Benchmarking
- 14.5.4 Strategic Outlook
- 14.6 Navitas Life Sciences
- 14.6.1 Company Snapshot
- 14.6.2 Company Overview
- 14.6.3 Product Benchmarking
- 14.6.4 Strategic Outlook
- 14.7 Resonance Health Ltd
- 14.7.1 Company Snapshot
- 14.7.2 Company Overview
- 14.7.3 Financial Analysis
- 14.7.3.1 Revenue, 2018-2021
- 14.7.3.2 Regional Market Shares, 2021
- 14.7.4 Product Benchmarking
- 14.8 Parexel International Corporation
- 14.8.1 Company Snapshot
- 14.8.2 Company Overview
- 14.8.3 Product Benchmarking
- 14.8.4 Strategic Outlook
- 14.9 Medrio, Inc.
- 14.9.1 Company Snapshot
- 14.9.2 Company Overview
- 14.9.3 Product Benchmarking
- 14.9.4 Strategic Outlook
- 14.10 Signant Health
- 14.10.1 Company Snapshot
- 14.10.2 Company Overview
- 14.10.3 Product Benchmarking
- 14.10.4 Strategic Outlook
- 14.11 Perspectum
- 14.11.1 Company Snapshot
- 14.11.2 Company Overview
- 14.11.3 Product Benchmarking
- 14.11.4 Strategic Outlook
- 14.12 Medical Metrics, Inc.
- 14.12.1 Company Snapshot
- 14.12.2 Company Overview
- 14.12.3 Product Benchmarking
- 14.13 Calyx
- 14.13.1 Company Snapshot
- 14.13.2 Company Overview
- 14.13.3 Product Benchmarking
- 14.13.4 Strategic Outlook
- 14.14 Radiant Sage LLC
- 14.14.1 Company Snapshot
- 14.14.2 Company Overview
- 14.14.3 Product Benchmarking
- 14.15 Medpace
- 14.15.1 Company Snapshot
- 14.15.2 Company Overview
- 14.15.3 Financial Analysis
- 14.15.3.1 Revenue, 2018-2022
- 14.15.3.2 Regional Market Shares, 2021
- 14.15.4 Product Benchmarking
- 14.16 IXICO plc
- 14.16.1 Company Snapshot
- 14.16.2 Company Overview
- 14.16.3 Financial Analysis
- 14.16.3.1 Revenue, 2018-2022
- 14.16.3.2 Regional Market Shares, 2021
- 14.16.3.3 R&D Expense, 2017-2021
- 14.16.4 Product Benchmarking
- 14.16.5 Strategic Outlook
15 Conclusion and Recommendations
- 15.1 Concluding Remarks from
- 15.2 Recommendations for Market Players